Professor of Surgery
University of Louisville School of Medicine, Department of Surgery
Louisville, Kentucky, United States
Robert C.G. Martin, II, M.D. PhD, is The Sam and Lolita Weakley Endowed Chair in Surgical Oncology, The Director of the Division of Surgical Oncology, faculty member of the James Graham Brown Cancer Center, and a Professor in the Department of Surgery. He was appointed to the University of Louisville in 2002 as an Assistant Professor and achieved Professor of Surgery in 2011. Dr. Martin received his M.D. from the University of Louisville School of Medicine(1995) and his surgical oncology training and hepato-pancreatico-biliary training from Memorial Sloan-Kettering Cancer Center(2002), and his PhD from the Department of Pharmacology and Toxiciology(2008) at the University of Louisville School of Medicine.
He has completed over 15 prospective clinical trials and principle investigator of 1 Humanitarin Device Exemption(HDE), 2 Investigation New Drugs(IND), and 3 Investigational Device Exemption(IDE) trials. He has completed over 5 NIH funded grants and continue to maintain an active basic science laboratory.
Dr. Martin’s clinical interests are focused on the multi-disciplinary care and surgical management of patients with upper GI malignancies, including esophageal, gastric, duodenal, liver, biliary, and pancreatic cancers.
His Clinical Research Interests are focused in Hepatocellular Cancer, Metastatic Colorectal Cancer, Cholangiocarcinoma(Bile Duct Cancer), Pancreatic Cancer, Gastric Cancer, and Esophageal Cancer with specific trials in all of these disease.
His research focus is surgical quality of care, metastatic colon cancer management and genetic predispositions to upper GI malignancies.
Dr. Martin’s basic science interest focuses on the translational research - defined as animal model evaluation in esophageal, hepatocellular, and pancreatic cancers – for naturally occurring chemoprevention therapeutics, nanoparticle and gold particle targeted therapy, as well as optimal device evaluation.
- He has written more than 400 first or senior author peer review manuscripts and is currently the Principal Investigator of multiple clinical trials evaluating new technology in the Hepato-Pancreatico-Biliary patient.
https://www.ncbi.nlm.nih.gov/pubmed/?term=(Martin+RC)+and+(louisville)
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Saturday, March 12, 2022
11:21 AM – 11:29 AM CST
Saturday, March 12, 2022
11:29 AM – 11:30 AM CST